Growth Metrics

Kyverna Therapeutics (KYTX) Shareholder's Equity (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Kyverna Therapeutics 497.98 Mn 265.03 Mn - 195.58 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 195.58 Mn
Dec 31, 2025 232.28 Mn
Sep 30, 2025 151.95 Mn
Jun 30, 2025 184.38 Mn
Mar 31, 2025 224.01 Mn
Dec 31, 2024 266.59 Mn
Sep 30, 2024 302.71 Mn
Jun 30, 2024 333.51 Mn
Mar 31, 2024 360.99 Mn
Dec 31, 2023 -13.14 Mn
Sep 30, 2023 -111.81 Mn
Jun 30, 2023 -97.20 Mn
Mar 31, 2023 -84.61 Mn